MoonLake Immunotherapeutics MLTX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's total current liabilities?
- MoonLake Immunotherapeutics (MLTX) reported total current liabilities of $46.11M in Q1 2026.
- How has MoonLake Immunotherapeutics's total current liabilities changed year-over-year?
- MoonLake Immunotherapeutics's total current liabilities increased by 92.3% year-over-year, from $23.98M to $46.11M.
- What is the long-term trend for MoonLake Immunotherapeutics's total current liabilities?
- Over 5 years (2020 to 2025), MoonLake Immunotherapeutics's total current liabilities has grown at a 225.1% compound annual growth rate (CAGR), from $125.18K to $45.48M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.